Attitudes and experiences with levonorgestrel 100 μg/ethinyl estradiol 20 μg among women during a 3-month trial

被引:10
作者
Wimberly, YH
Cotton, S
Wanchick, AM
Succop, PA
Rosenthal, SL [1 ]
机构
[1] Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77550 USA
[2] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA
[3] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45221 USA
关键词
oral contraceptive pills; contraception; satisfaction; women's health; side effects; weight gain; levonorgestrel;
D O I
10.1016/S0010-7824(02)00314-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
To describe attitudes and experiences with a low-dose oral contraceptive pill (Alesse) over 3 months, women aged 18 years and older (n = 218) were enrolled from 16 locations to evaluate their experiences with Alesse. The questionnaire assessed demographic and personal characteristics, attitudes and experiences, and satisfaction. The participants had a mean age of 26.7 years and most were single, Caucasian, had completed high school, had a regular sexual partner, and had previously used OCs. Sixty percent of participants could discuss pill use easily with their mothers, 92% with friends, and 96% with partners; 45% of the women were unsure about their mother's previous OC use. Of the I I side effects assessed, the most frequently anticipated side effect was weight gain. There was a significant relationship between anticipated and reported side effects for weight and mood changes; however, there remained a number of women for whom these differed. Most (90%) were satisfied with Alesse. Even when beginning on 20 mug pills, some women may still anticipate side effects such as weight gain typically associated with higher doses of estrogen. Healthcare providers should assess women's attitudes and anticipated experiences with OCs and counsel accordingly. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:403 / 406
页数:4
相关论文
共 6 条
[1]   Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials [J].
Coney, P ;
Washenik, K ;
Langley, RGB ;
DiGiovanna, JJ ;
Harrison, DD .
CONTRACEPTION, 2001, 63 (06) :297-302
[2]  
CROMER BA, 1994, PEDIATRICS, V94, P687
[3]  
LANDIS JR, 1977, BIOMETRICS, V33, P366
[4]   Weight change in adolescents who used hormonal contraception [J].
Risser, WL ;
Gefter, LR ;
Barratt, MS ;
Risser, JMH .
JOURNAL OF ADOLESCENT HEALTH, 1999, 24 (06) :433-436
[5]   Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives:: A randomized trial of 20 μg and 35 μg estrogen preparations [J].
Rosenberg, MJ ;
Meyers, A ;
Roy, V .
CONTRACEPTION, 1999, 60 (06) :321-329
[6]  
SAS, 1990, SAS STAT US GUID